{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:51:39Z","timestamp":1793904699312,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Von Willebrand disease (VWD) is a common bleeding disorder caused by mutations in the von Willebrand factor gene (\n                    <jats:italic>VWF<\/jats:italic>\n                    ). The true global prevalence of VWD has not been accurately established. We estimated the worldwide and within-population prevalence of inherited VWD by analyzing exome and genome data of 141,456 individuals gathered by the genome Aggregation Database (gnomAD). We also extended our data deepening by mining the main databases containing\n                    <jats:italic>VWF<\/jats:italic>\n                    variants i.e., the Leiden Open Variation Database (LOVD) and the Human Gene Mutation Database (HGMD) with the goal to explore the global mutational spectrum of VWD. A total of 4,313\n                    <jats:italic>VWF<\/jats:italic>\n                    variants were identified in the gnomAD population, of which 505 were predicted to be pathogenic or already reported to be associated with VWD. Among the 282,912 alleles analyzed, 31,785 were affected by the aforementioned variants. The global prevalence of dominant VWD in 1000 individuals was established to be 74 for type 1, 3 for 2A, 3 for 2B and 6 for 2M. The global prevalences for recessive VWD forms (type 2N and type 3) were 0.31 and 0.7 in 1000 individuals, respectively. This comprehensive analysis provided a global mutational landscape of\n                    <jats:italic>VWF<\/jats:italic>\n                    by means of 927 already reported variants in the HGMD and LOVD datasets and 287 novel pathogenic variants identified in the gnomAD. Our results reveal that there is a considerably higher than expected prevalence of putative disease alleles and variants associated with VWD and suggest that a large number of VWD patients are undiagnosed.\n                  <\/jats:p>","DOI":"10.1038\/s41525-023-00375-8","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:02:39Z","timestamp":1697457759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases"],"prefix":"10.1038","volume":"8","author":[{"given":"Omid","family":"Seidizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-0345","authenticated-orcid":false,"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"375_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1172\/JCI119195","volume":"99","author":"ZM Ruggeri","year":"1997","unstructured":"Ruggeri, Z. M. von Willebrand factor. J. Clin. Investig. 99, 559\u2013564 (1997).","journal-title":"J. Clin. Investig."},{"key":"375_CR2","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3390\/cells10092351","volume":"10","author":"A Mojzisch","year":"2021","unstructured":"Mojzisch, A. & Brehm, M. A. The manifold cellular functions of von willebrand factor. Cells 10, 2351 (2021).","journal-title":"Cells"},{"key":"375_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","volume":"120","author":"YF Zhou","year":"2012","unstructured":"Zhou, Y. F. et al. Sequence and structure relationships within von Willebrand factor. Blood 120, 449\u2013458 (2012).","journal-title":"Blood"},{"key":"375_CR4","first-page":"s3_s8","volume":"9","author":"F Peyvandi","year":"2011","unstructured":"Peyvandi, F., Garagiola, I. & Baronciani, L. Role of von Willebrand factor in the haemostasis. Blood Transfus. 9, s3_s8. (2011).","journal-title":"Blood Transfus."},{"key":"375_CR5","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1111\/jth.12008","volume":"10","author":"PJ Lenting","year":"2012","unstructured":"Lenting, P. J., Casari, C., Christophe, O. D. & Denis, C. V. von Willebrand factor: the old, the new and the unknown. J. Thrombosis Haemost. 10, 2428\u20132437 (2012).","journal-title":"J. Thrombosis Haemost."},{"key":"375_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1126\/science.3874428","volume":"228","author":"D Ginsburg","year":"1985","unstructured":"Ginsburg, D. et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 228, 1401\u20131406 (1985).","journal-title":"Science"},{"key":"375_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","volume":"41","author":"DC Lynch","year":"1985","unstructured":"Lynch, D. C. et al. Livingston, Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell 41, 49\u201356 (1985).","journal-title":"Cell"},{"key":"375_CR8","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","volume":"82","author":"JE Sadler","year":"1985","unstructured":"Sadler, J. E. et al. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc. Natl. Acad. Sci. USA 82, 6394\u20136398 (1985).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"375_CR9","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1093\/nar\/13.13.4699","volume":"13","author":"CL Verweij","year":"1985","unstructured":"Verweij, C. L. et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony screening and mapping of the chromosomal gene. Nucleic Acids Res. 13, 4699\u20134717 (1985).","journal-title":"Nucleic Acids Res."},{"key":"375_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1021\/bi00215a036","volume":"30","author":"DJ Mancuso","year":"1991","unstructured":"Mancuso, D. J. et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 30, 253\u2013269 (1991).","journal-title":"Biochemistry"},{"key":"375_CR11","first-page":"2103","volume":"4","author":"JE Sadler","year":"2006","unstructured":"Sadler, J. E. et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. JTH 4, 2103\u20132114 (2006).","journal-title":"JTH"},{"key":"375_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2017.09.025","volume":"159","author":"A de Jong","year":"2017","unstructured":"de Jong, A. & Eikenboom, J. Von Willebrand disease mutation spectrum and associated mutation mechanisms. Thrombosis Res. 159, 65\u201375 (2017).","journal-title":"Thrombosis Res."},{"key":"375_CR13","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1182\/bloodadvances.2020003397","volume":"5","author":"L Baronciani","year":"2021","unstructured":"Baronciani, L. et al. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. Blood Adv. 5, 2987\u20133001 (2021).","journal-title":"Blood Adv."},{"key":"375_CR14","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jth.15713","volume":"20","author":"PA Christopherson","year":"2022","unstructured":"Christopherson, P. A. et al. Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program. J. Thromb. Haemost. 20, 1576\u20131588 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"375_CR15","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","volume":"6","author":"O Seidizadeh","year":"2022","unstructured":"Seidizadeh, O. et al. Phenotypic and genetic characterization of the Milan cohort of von Willebrand disease type 2. Blood Adv. 6, 4031\u20134040 (2022).","journal-title":"Blood Adv."},{"key":"375_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","volume":"69","author":"F Rodeghiero","year":"1987","unstructured":"Rodeghiero, F., Castaman, G. & Dini, E. Epidemiological investigation of the prevalence of von Willebrand\u2019s disease. Blood 69, 454\u2013459 (1987).","journal-title":"Blood"},{"key":"375_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","volume":"123","author":"EJ Werner","year":"1993","unstructured":"Werner, E. J. et al. Prevalence of von Willebrand disease in children: a multiethnic study. J. Pediatr. 123, 893\u2013898 (1993).","journal-title":"J. Pediatr."},{"key":"375_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","volume":"8","author":"M Bowman","year":"2010","unstructured":"Bowman, M., Hopman, W. M., Rapson, D., Lillicrap, D. & James, P. The prevalence of symptomatic von Willebrand disease in primary care practice. J. Thrombosis Haemost. 8, 213\u2013216 (2010).","journal-title":"J. Thrombosis Haemost."},{"key":"375_CR19","doi-asserted-by":"crossref","unstructured":"Bloom, Al. von Willebrand factor: clinical features of inherited and acquired disorders. In Mayo Clinic Proceedings 1991 Jul 1 (Vol. 66, pp. 743\u2013751).","DOI":"10.1016\/S0025-6196(12)62088-6"},{"key":"375_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jamadermatol.2018.4473","volume":"155","author":"J Pugh","year":"2019","unstructured":"Pugh, J. et al. Use of big data to estimate prevalence of defective DNA repair variants in the US Population. JAMA Dermatol. 155, 72\u201378 (2019).","journal-title":"JAMA Dermatol."},{"key":"375_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17564-y","volume":"7","author":"BG Hughes","year":"2017","unstructured":"Hughes, B. G., Harrison, P. M. & Hekimi, S. Estimating the occurrence of primary ubiquinone deficiency by analysis of large-scale sequencing data. Sci. Rep. 7, 17744 (2017).","journal-title":"Sci. Rep."},{"key":"375_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2017-04-780148","volume":"130","author":"R Asselta","year":"2017","unstructured":"Asselta, R. et al. Exploring the global landscape of genetic variation in coagulation factor XI deficiency. Blood 130, e1\u2013e6 (2017).","journal-title":"Blood"},{"key":"375_CR23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/hae.13292","volume":"23","author":"RF Sidonio","year":"2017","unstructured":"Sidonio, R. F., Haley, K. M. & Fallaize, D. Impact of diagnosis of von Willebrand disease on patient outcomes: Analysis of medical insurance claims data. Haemophilia 23, 743\u2013749 (2017).","journal-title":"Haemophilia"},{"key":"375_CR24","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.blre.2022.101018","volume":"58","author":"FF Corrales-Medina","year":"2023","unstructured":"Corrales-Medina, F. F. et al. A need to increase von Willebrand disease awareness: vwdtest.com - A global initiative to help address this gap. Blood Rev. 58, 101018 (2023).","journal-title":"Blood Rev."},{"key":"375_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/blood-2013-02-485094","volume":"122","author":"JM Johnsen","year":"2013","unstructured":"Johnsen, J. M. et al. NHLBI Exome Sequencing Project. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood 122, 590\u2013597 (2013).","journal-title":"Blood"},{"key":"375_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/jth.12093","volume":"11","author":"QY Wang","year":"2013","unstructured":"Wang, Q. Y. et al. Characterizing polymorphisms and allelic diversity of von W illebrand factor gene in the 1000 Genomes. J. Thrombosis Haemost. 11, 261\u2013269 (2013).","journal-title":"J. Thrombosis Haemost."},{"key":"375_CR27","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","volume":"119","author":"DB Bellissimo","year":"2012","unstructured":"Bellissimo, D. B. et al. VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population. Blood 119, 2135\u20132140 (2012).","journal-title":"Blood"},{"key":"375_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00277-013-1817-y","volume":"93","author":"DJ Hampshire","year":"2014","unstructured":"Hampshire, D. J. Goodeve AC. p.P2063S: a neutral VWF variant masquerading as a mutation. Ann. Hematol. 93, 505\u2013506 (2014).","journal-title":"Ann. Hematol."},{"key":"375_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/gim.2013.176","volume":"16","author":"X Jian","year":"2014","unstructured":"Jian, X., Boerwinkle, E. & Liu, X. In silico tools for splicing defect prediction: a survey from the viewpoint of end users. Genet. Med. 16, 497\u2013503 (2014).","journal-title":"Genet. Med."},{"key":"375_CR30","doi-asserted-by":"crossref","first-page":"100602","DOI":"10.1016\/j.ymgmr.2020.100602","volume":"24","author":"SG Kaler","year":"2020","unstructured":"Kaler, S. G., Ferreira, C. R. & Yam, L. S. Estimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD). Mol. Genet. Metab. Rep. 24, 100602 (2020).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"375_CR31","first-page":"516","volume":"40","author":"T Soussi","year":"2019","unstructured":"Soussi, T., Leroy, B., Devir, M. & Rosenberg, S. High prevalence of cancer\u2010associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering. Hum. Mutat. 40, 516\u2013524. (2019).","journal-title":"Hum. Mutat."},{"key":"375_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"375_CR33","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. & Krainer, A. R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acid Res. 31, 3568\u20133571. (2003).","journal-title":"Nucleic Acid Res."},{"key":"375_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","volume":"4","author":"MG Reese","year":"1997","unstructured":"Reese, M. G., Eeckman, F. H., Kulp, D. & Haussler, D. Improved splice site detection in genie. J. Comp. Biol. 4, 311\u2013323 (1997).","journal-title":"J. Comp. Biol."},{"key":"375_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00835-9","volume":"13","author":"P Rentzsch","year":"2021","unstructured":"Rentzsch, P., Schubach, M., Shendure, J. & Kircher, M. CADD-Splice\u2014improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 13, 31 (2021).","journal-title":"Genome Med."},{"key":"375_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081 (2009).","journal-title":"Nat. Protoc."},{"key":"375_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"375_CR38","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01734359","volume":"17","author":"J Felsenstein","year":"1981","unstructured":"Felsenstein, J. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17, 368\u2013376 (1981).","journal-title":"J. Mol. Evol."},{"key":"375_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575\u2013576 (2010).","journal-title":"Nat. Methods"},{"key":"375_CR40","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res. 39, e118 (2011).","journal-title":"Nucleic Acids Res."},{"key":"375_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.22225","volume":"34","author":"HA Shihab","year":"2013","unstructured":"Shihab, H. A. et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum. Mutat. 34, 57\u201365 (2013).","journal-title":"Hum. Mutat."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-023-00375-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-023-00375-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-023-00375-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:48:33Z","timestamp":1730314113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-023-00375-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1038\/s41525-023-00375-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2454413\/v1","asserted-by":"object"}]},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.P. reports participation at educational meetings and the advisory board of Sanofi, Sobi, Takeda, Roche and Biomarin. The other authors state that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}